Sobre companhia

BlueSphere Bio was founded to deploy its novel TCXpress technology to unlock the potential of personalized T-cell therapy for the treatment of cancer by harnessing the unique specificity of each patient’s own T-cells for the particular molecular fingerprint of each patient’s own cancer.

US
Desconhecido
Empresa não verificada